For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and the formulated version represents a genuine breakthrough . These novel therapies stabilize the transthyretin protein, slowing its harmful build-up and alleviating t